KATHERINE CALLAHAN: Open Payments
NPI 1780766972 · LAPEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,219 in 108 payments from 23 companies in 2025. Trend: 2023 $1,294 · 2024 $1,528 · 2025 $2,219
Food & beverage: $2,144Education: $75
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $436 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $249 |
| Exact Sciences Corporation | 7 | $193 |
| Novo Nordisk Inc | 16 | $179 |
| PFIZER INC. | 14 | $171 |
| Amgen Inc. | 13 | $140 |
| Medtronic, Inc. | 2 | $113 |
| Lilly USA, LLC | 5 | $107 |
| HARMONY BIOSCIENCES LLC | 2 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
Products named: BREZTRI, Kerendia, The Cologuard Plus Collection Kit, OTEZLA, AIRSUPRA, INTELLIS ADAPTIVESTIM, PREVNAR 20, MOUNJARO.
Industry payments across IN — which companies pay providers there.
